Inappropriate sinus tachycardia treatment guidelines

Revision as of 15:24, 26 February 2013 by Prashanthsaddala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Inappropriate sinus tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Inappropriate Sinus Tachycardia from other Medical Conditions

Epidemiology and Demographics

Diagnosis

Diagnostic Criteria

History and Symptoms

Electrocardiogram

Treatment

ACC/AHA/ESC Treatment Guidelines

Medical Therapy

Surgery

Case Studies

Case #1

Inappropriate sinus tachycardia treatment guidelines On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Inappropriate sinus tachycardia treatment guidelines

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Inappropriate sinus tachycardia treatment guidelines

CDC on Inappropriate sinus tachycardia treatment guidelines

Inappropriate sinus tachycardia treatment guidelines in the news

Blogs on Inappropriate sinus tachycardia treatment guidelines

Directions to Hospitals Treating Inappropriate sinus tachycardia

Risk calculators and risk factors for Inappropriate sinus tachycardia treatment guidelines

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

ACC/AHA/ESC Practice Guidelines. Recommendations for Treatment of Inappropriate Sinus Tachycardia[1] (DO NOT EDIT)

Class I

Medical

1) Beta blockers (Level of Evidence: C)

Class IIa

1) Verapamil, diltiazem (Level of Evidence: C)

Class IIb

Interventional

1) Catheter ablation-sinus node modification/elimination (Used as a last resort) (Level of Evidence: C)


References

  1. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ (2003). "ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society". Journal of the American College of Cardiology. 42 (8): 1493–531. PMID 14563598. Retrieved 2012-09-12. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources